Acrivon Therapeutics
ACRV
ACRV
40 hedge funds and large institutions have $196M invested in Acrivon Therapeutics in 2023 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 17 increasing their positions, 11 reducing their positions, and 4 closing their positions.
Holders
40
Holders Change
+1
Holders Change %
+2.56%
% of All Funds
0.63%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
5
Increased
17
Reduced
11
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
